Products

What will AGI do for Alinidine?

This classification denotes an alpha-adrenergic agonist with the molecular formula C12H13Cl2N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7IDJ8DS1D, chemically known as 2-(n-allyl-n-(2,6-dichlorophenyl)amino)-2-imidazoline but generally known as alinidine, which bears US NIH Compound Identifier 36354. Alinidine most often comes in base and hydrobromide forms. European Medicines Agency schedules Alinidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05330MIG. The term ALINIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). ALINIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alinidine under HS 29332990 and SITC 51573. As of Q4 2014, ALINIDINE remains the US FDA Preferred Term for this commodity. Alinidine bears US NLM identifiers UMLS ID C0102151 and NCI Concept Code C72571. SMILES: C=CCN(C1=C(C=CC=C1Cl)Cl)C2=NCCN2.